Skip to Main Content

Paper Details

A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial.
Clin Cancer Res
8
2020
Author NameAffiliation
Peter A FaschingUniversity Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg
Jan Budczies
  • 1 - 2

Datasets

Release 1.2